Browsing by Subject "Gastrointestinal (GI)"

Now showing items 1-2 of 2

Multinational Association of Supportive Care in Cancer (MASCC) 2020 clinical practice recommendations for the management of severe gastrointestinal and hepatic toxicities from checkpoint inhibitors

Dougan, Michael; Blidner, Ada Gabriela; Choi, Jennifer; Cooksley, Tim; Glezerman, Ilya; Ginex, Pamela; Girotra, Monica; Gupta, Dipti; Johnson, Douglas; Shannon, Vickie R.; Suarez-Almazor, Maria; Anderson, Ronald; Rapoport, Bernardo Leon (Springer, 2020-12)

Immune-related adverse events (IrAEs) affecting the gastrointestinal (GI) tract and liver are among the most frequent and most severe inflammatory toxicities from contemporary immunotherapy. Inflammation of the colon and ...
Ok, so who wants to colonise my gut? - Overview of probiotics in certain gastro-intestinal disorders

Muntingh, George L. (Medpharm Publications, NISC (Pty) Ltd and Cogent, Taylor and Francis Group, 2017)

Probiotics are being used and perhaps more often than not as a treatment for a variety of gastrointestinal (GI) disorders. With increasing frequency, it is also being advocated as a treatment for several medical conditions, ...

Search UPSpace